Clough Capital Partners’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-535,200
Closed -$14.4M 151
2021
Q2
$14.4M Buy
535,200
+123,100
+30% +$3.44M 0.79% 55
2021
Q1
$12.4M Sell
412,100
-156,700
-28% -$5.34M 0.55% 60
2020
Q4
$16.3M Buy
+568,800
New +$15.4M 1.16% 32

Other funds holding CVET

Clough Capital Partners's CVET Position: Q3 2021 in Review

Clough Capital Partners sold out of Covetrus, Inc. Common Stock (CVET) in Q3 2021, closing a stake of 535,200 shares — an estimated $14.4M sold.

Clough Capital Partners first reported a position in CVET in Q4 2020 and held it in 3 quarters. The position peaked at $16.3M in Q4 2020. 260 funds tracked by Wall St. Rank hold CVET as of Q3 2021.

  • Clough Capital Partners reported no remaining Covetrus, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Clough Capital Partners sold 535,200 Covetrus, Inc. Common Stock shares in Q3 2021, an estimated $14.4M.
  • Clough Capital Partners first reported a position in Covetrus, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
  • Clough Capital Partners's Covetrus, Inc. Common Stock position peaked at $16.3M in Q4 2020.
  • 260 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q3 2021.

Based on Clough Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.